Pharmafile Logo

Canning

Since 1965 we have helped people like you to communicate more effectively while doing business across borders. The worldwide web is full of companies offering to do these things for you. What makes us different? Explore our website and have a look. Or, even better, contact us and talk to one of our team about what we could do for you and your organisation. Our existing clients know we are the best. You need to discover that for yourself.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

593-599 Fulham Road, Fulham Broadway, London, SW6 5UA, United Kingdom
+44 (0)20 7381 7410

 Latest Content from PMHub 

5 Ways to Communicate With Millennials About Healthcare

What does it mean to be a millennial? Opinions vary greatly and it is difficult to disagree on the exact definition. Metro explained the generation as babies born from the...

Webcast: Poker face revealed: Using facial analysis to uncover deeper levels of emotional insight

In the first part of our series covering market research innovations which have value in healthcare, we demonstrate how we've been using facial analysis to delve further into respondents' reactions...

Report: Living with RA (EU, Japan and Canada) 2019 reports

Research Partnership launches new patient Living with  Rheumatoid Arthritis (EU & Japan)  2019 report.r Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in...

News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter. In addition from Q1...

Emerging Markets: Your Essential Guide

Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges...

Live webinar: Navigating new frontiers: Ways to find space in the future RA market

In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...

Bluedog Launch Celebrations

Teams from all companies within the Lucid Group and Bluedog gathered to celebrate both the launch of this new partnership and Lucid Group’s twelve-year anniversary.  2019 is set to be a...

Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis

An interview with Debbie, office manager at Porterhouse Medical, on what it’s like to live with the rare disease, PSC. Read more ...

Rare Disease Day 2019

Today is #RareDiseaseDay and is an opportunity to highlight some truly unbelievable/frightening statistics around rare diseases.

Health Literacy in Practice: Doctor’s Letter

If a patient was given their results directly, how could we make it into something they could understand and, most importantly, act on?